These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11407096)

  • 1. Severe myelotoxicity in rheumatoid arthritis patients treated with oral methotrexate.
    Rodriguez-Gomez M; Fernandez-Sueiro JL; Ulibarrena C; Lopez-Barros G; Willisch A; Fernandez-Dominguez L
    Clin Exp Rheumatol; 2001; 19(3):353. PubMed ID: 11407096
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.
    Hameed B; Jones H
    Int J Rheum Dis; 2010 Oct; 13(4):e83-4. PubMed ID: 21199461
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long-term methotrexate for rheumatoid arthritis.
    White DH; Chapman PT; O'Donnell JL; James J; Frampton C; Stamp LK
    Intern Med J; 2010 Aug; 40(8):561-5. PubMed ID: 19811562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pausing paw proliferation.
    Schubert C
    Nat Med; 2003 Jun; 9(6):643. PubMed ID: 12778155
    [No Abstract]   [Full Text] [Related]  

  • 5. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
    Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
    Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of AST changes in patients with rheumatoid arthritis treated with methotrexate.
    Heathcote J
    J Rheumatol; 1996 Mar; 23(3):413-5. PubMed ID: 8832974
    [No Abstract]   [Full Text] [Related]  

  • 7. Etanercept and methotrexate in rheumatoid arthritis.
    Malgarini RB; Pimpinella G
    Lancet; 2004 May; 363(9422):1733; author reply 1733. PubMed ID: 15158641
    [No Abstract]   [Full Text] [Related]  

  • 8. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.
    Rozin A; Schapira D; Balbir-Gurman A; Braun-Moscovici Y; Markovits D; Militianu D; Nahir MA
    Ann Rheum Dis; 2002 Aug; 61(8):756-7. PubMed ID: 12117691
    [No Abstract]   [Full Text] [Related]  

  • 9. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.
    Wegrzyn J; Adeleine P; Miossec P
    Ann Rheum Dis; 2004 Oct; 63(10):1232-4. PubMed ID: 15361377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
    Raghu P; Grover PS; Kumar A
    Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
    [No Abstract]   [Full Text] [Related]  

  • 11. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 12. SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patients.
    Eektimmerman F; Swen JJ; Böhringer S; Aslibekyan S; Allaart CF; Guchelaar HJ
    Pharmacogenomics; 2018 May; 19(7):613-619. PubMed ID: 29701127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose oral methotrexate in the treatment of rheumatoid polyarthritis].
    Chamot AM; Gerster JC; Van Melle G
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1267-71. PubMed ID: 3175573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA.
    Rau R
    J Rheumatol; 2005 Jul; 32(7):1412; author reply 1412-3. PubMed ID: 15996092
    [No Abstract]   [Full Text] [Related]  

  • 15. Herpes zoster encephalomyelitis in a patient with rheumatoid arthritis treated with low dose methotrexate.
    Golden HE
    J Rheumatol; 1997 Dec; 24(12):2487-8. PubMed ID: 9415667
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy: oral or subcutaneous methotrexate for rheumatoid arthritis?
    Alsaeedi S; Keystone EC
    Nat Rev Rheumatol; 2014 Oct; 10(10):578-9. PubMed ID: 25090946
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral methotrexate: the hazard of different tablet strengths.
    Schott JM; Rigby SP; McNally JD; Keat A; Higgens CS
    Rheumatology (Oxford); 1999 Apr; 38(4):382. PubMed ID: 10378725
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of combination therapies in rheumatoid arthritis: comment on the article by Willkens et al.
    Stein CM
    Arthritis Rheum; 1996 Aug; 39(8):1435-7. PubMed ID: 8702459
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Malleson P
    N Engl J Med; 1995 Dec; 333(23):1567; author reply 1568-9. PubMed ID: 7477177
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.